- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
KFF: More Than A Third of Americans Have Anxiety, Depression Symptoms
More than a third of American adults now have symptoms that are consistent with anxiety and depressive disorders, according to the Kaiser Family Foundation.
Using survey data collected by the U.S. Census Bureau in June, the foundation's research calculated that 36.5% of American adults are reporting anxiety and depressive systems compared with 11% in 2019.
The foundation's own polling has shown that a large proportion of Americans say they are worried about, and have stress related to, COVID-19.
Louisiana (42.9%), Florida (41.5%), Oregon (41.3%), Nevada (39.1%), and Oklahoma (39%) are the states with the highest percentage of adults with anxiety and depression systems, according to the foundation.
Wisconsin (27.2%), Minnesota (30.%), Nebraska (30.6%), North Dakota (30.9%) and South Dakota (315) are the states with the lowest percentage.
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
